当前位置:主页 > 医学论文 > 麻醉学论文 >

Lgr5通过VEGF介导的血管生成调节结直肠癌的转移

发布时间:2018-05-09 04:15

  本文选题:结直肠癌 + 肿瘤转移 ; 参考:《南方医科大学》2014年硕士论文


【摘要】:研究背景 结直肠癌已成为我国发病率增长最快的恶性肿瘤之一,然而在结直肠癌相关性死亡中,大部分为转移癌所致。近年来越来越多的研究聚焦于肿瘤转移,并不断探索肿瘤转移的机制,旨在减少肿瘤转移的发生,降低转移癌的死亡率。肿瘤血管生成是肿瘤生长以及肿瘤转移过程中非常重要的环节,VEGF是促进血管生成的重要因子,在肿瘤血管生成中也具有重要作用。目前有实验通过抑制VEGF的生成来抑制肿瘤血管形成,从而抑制肿瘤,但是对于结直肠癌的转移抑制作用不明显。因此,有必要进一步研究VEGF在结直肠癌形成以及转移过程中的机制。 近年来,研究发现Lgr5为小肠、结肠以及毛囊等组织的干细胞特异性分子标记物,并且在肝细胞癌、结肠癌、卵巢癌、基底细胞癌以及胃癌等实体肿瘤中高表达。Lgr5是Wnt信号通路的靶基因,并且可以反馈性地调节Wnt信号通路的活性,从而调控细胞的生长、运动和分化。越来越多的研究证实,Lgr5可能也为结直肠癌的肿瘤干细胞标记物,可以与其他肿瘤干细胞标记物一同用于结直肠癌肿瘤干细胞的筛选。根据“肿瘤干细胞学说”,有数据表明,结直肠癌可能来源于隐窝基底部Lgr5阳性的干细胞。这就证明Lgr5可能对于结直肠癌的发生发展具有重要作用。然而,目前关于Lgr5在肿瘤形成、发展以及转移过程中的作用及其机制的研究较少。我们课题组前期证实在结直肠癌细胞中敲低Lgr5的表达后可以抑制肿瘤的血管生成。 研究目的 为了避免单方面敲低Lgr5表达引起实验结果的偶然性以及进一步探讨Lgr5在结直肠癌及其转移癌中的作用,Lgr5对VEGF的影响及其机制,为以Lgr5为靶点的结直肠癌治疗提供理论依据。 研究方法 1.构建Lgr5过表达质粒并建立稳定细胞株 根据完整的人Lgr5(NM_003667)基因序列信息设计其编码区扩增引物,引物序列见表一,引物扩增总长度为2745bps。将其克隆到pcDNA3.1(+)真核表达载体中,经检测序列正确。利用Lipofectamine2000将pcDNA3.1(+)-Lgr5质粒、pcDNA3.1(+)空载体质粒瞬时转染入SW480细胞,48小时后,以1000ug/mlG418进行连续筛选,约2-3周挑克隆并扩大培养,以600ug/mlG418继续维持。 2. Western blotting 提取细胞的总蛋白,用BCA蛋白质定量试剂盒检测蛋白浓度,蛋白质样品上样量为20μg。电泳后将蛋白质电转至PVDF膜,5%脱脂牛奶封闭,4℃孵育一抗过夜,一抗稀释比例为(Lgr51:500, VEGF1:200, GAPDH1:1000,β-actin 1:1000),次日二抗孵育1小时,ECL化学发光法显影。 3.实时荧光定量PCR (qRT-PCR) 提取细胞、组织总RNA并测定RNA浓度,用M-MLV逆转录酶合成cDNA第一链,使用Takara的SYBR Premix Ex Taq试剂盒进行实时荧光定量PCR,引物序列见表一。 4.免疫组织化学(SP法) 收集南方医院结直肠原发癌标本58例,结直肠癌转移癌标本8例,组织经10%福尔马林固定,石蜡包埋,标本切成4μm薄片,65℃烤箱烤片约3小时,依次脱蜡水化,以0.01M枸橼酸钠缓冲液(pH6.0)高温微波修复15mmin,利用迈新公司UltraSensitiveS-P超敏试剂盒,一抗4℃冰箱孵育过夜(Lgr51:50、CD311:50),经DAB显色剂显色,苏木素复染,脱水透明,封片风干,显微镜下观察并拍片,两个病理科医生分别独立阅片并评分。 5.HE染色 组织经10%福尔马林固定,石蜡包埋,标本切成4μ.m薄片,65℃烤箱烤片约30分钟,依次脱蜡水化,苏木素染色2-5分钟,1%盐酸酒精分化,流水冲洗返蓝15分钟,伊红染色数秒至数分钟,脱水透明,封片晾干,显微镜下观察并拍片。 6. Transwell小室迁移与侵袭实验 将100u1浓度为以1x106/ml的细胞悬液加于上室,然后将500u1含10%FBS的培养基加于下室,培养24小时后,取出小室,4%多聚甲醛将细胞固定30分钟,结晶紫中染色10分钟,用棉签擦掉上室残留细胞,显微镜下随机选取5个视野进行细胞计数。侵袭实验在上室铺有一层基质胶,其余方法及操作均同迁移实验。 7.小管形成实验 质粒瞬时转染后48小时收集培养基,经孔径为0.22μmn的滤器分别过滤,收集为条件培养基。基质胶加入96孔板中,每孔加入50ul,37℃温度下交联1小时使胶固化。每孔加入50u1浓度为2×105/ml的HMVEC细胞,并且加入相应的条件培养基。于0h、2h、4h、8h在倒置显微镜下观察HMVEC细胞形成小管样结构的情况,并拍照,计数视野中小管样网状结构中的闭合环形小管结构的个数。 8. Elisa实验 根据人血管内皮生长因子(VEGF) Elisa试剂盒(武汉华美生物工程有限公司)的操作说明,检测重组细胞培养基中VEGF的浓度。 9. AOM/DSS模型的建立 选取5-6周balb/c小鼠,随机分成2组,每组10只。实验组用终浓度为1.25mg/ml的AOM按照12.5mg/kg的剂量腹腔注射一次(10ul/g),对照组以腹腔注射等剂量生理盐水。对照组不做特殊处理,实验组进行如下处理:第1周正常饮水;第2周饮水含2.5%DSS,第3、4周连续2周正常饮水,此为一个循环;第5-10周,重复第2、3、4周处理2次,即总共三个循环。继续饲养至17周,处死老鼠并取结肠组织,观察其瘤体情况,将结肠以10%福尔马林固定,石蜡包埋,行HE染色。提取结肠组织RNA,并进一步行实时荧光定量PCR检测Lgr5以及VEGF的表达量。 10.裸鼠成瘤与肝转移实验 裸鼠成瘤实验 选取5-6周Balb/c裸鼠,随机分成2组,每组7只,饲养等级为SPF级。分别注射SW620Lgr5shRNA细胞、SW620NC细胞至裸鼠背侧,调整细胞浓度为1×107/ml,注射200ul,注射细胞数为2×106个。观察裸鼠的成瘤情况,每隔3天称量裸鼠的体重,测量肿瘤的长径(L)以及宽径(W),以公式L×w2/2计算出瘤体的体积。4周后,裸鼠安乐死,并取下瘤体,经10%福尔马林固定石蜡包埋,供后续HE染色。 裸鼠结直肠癌肝转移实验 前期细胞准备与裸鼠同成瘤实验,以1%戊巴比妥钠6-8ul/g腹腔注射麻醉裸鼠,在裸鼠左侧背部取长约1cm小口,暴露脾脏,沿着脾门上缘从脾脏头侧进针向脾脏尾部注射,将100ul浓度为1×107/ml的细胞缓慢注入脾被膜下,注射成功后,清理腹腔,逐层关腹并逐层缝合,并以纱布包扎。观察裸鼠的生长状态,每隔3天称量裸鼠的体重。3周后,处死裸鼠,并取下脾脏、肝脏、肺脏等组织,经10%福尔马林固定石蜡包埋,供后续HE染色。 结果 1.免疫组化初步结果显示,在结直肠原发癌以及转移癌中,存在Lgr5表达越高,微血管密度(MVD)越高的趋势 对结直肠原发癌、淋巴结转移癌、肝转移癌组织标本进行免疫组织化学染色,检测Lgr5以及血管内皮标记物CD31的表达,发现Lgr5的表达在淋巴结转移癌与肝转移癌中表达更高,并且CD31的表达同样也升高,即微血管密度升高。免疫组化初步结果显示,在结直肠原发癌以及转移癌中,存在Lgr5表达越高,微血管密度(MVD)越高的趋势,然而这种趋势以及二者的相关性还需要通过进一步加大样本量,获得统计学数据加以证明。 2.成功构建高表达Lgr5的稳定细胞株 转染Lgr5重组过表达质粒pcDNA3.1(+)-Lgr5及pcDNA3.1(+)空载体质粒进入SW480并采用G418进行筛选,分别采用western blotting与实时荧光定量PCR技术检测Lgr5在SW480Lgr5与SW480vector中蛋白质以及mRNA的表达水平。结果发现,与SW480vector相比,Lgr5的蛋白质表达水平在SW480Lgr5细胞中明显升高;Lgr5的mRNA表达水平在SW480Lgr5细胞中同样明显升高(t=-17.499,p0.05)。 3.Lgr5对肿瘤细胞迁移与侵袭能力的影响 在迁移与侵袭实验中,与SW480vector细胞组相比,SW480Lgr5细胞组迁移与侵袭的细胞数明显增多(迁移:t=4.291,p0.05;侵袭:t=3.127,p0.05);与SW620NC细胞组相比,SW620Lgr5shRNA细胞组迁移与侵袭的细胞数明显减少(迁移:t=6.557,p0.01;侵袭:t=2.297, p0.05)。Transwell小室迁移与侵袭实验表明,升高Lgr5表达后肿瘤细胞的迁移与侵袭能力明显增强,敲除Lgr5表达后肿瘤细胞的迁移与侵袭能力明显减弱。 4.Lgr5对内皮细胞小管形成能力的影响 用内皮细胞在Matrigel中形成闭合环形小管的数目表示内皮细胞小管形成的能力。与SW480vector组相比,SW480Lgr5组小管样结构明显增多(t=8.617,p0.05);与SW620NC组相比,SW620Lgr5shRNA组小管样结构数明显减少(t=5.670,p0.05)。 5.Lgr5对结直肠癌细胞内血管内皮生长因子的影响 通过Western blotting发现,与SW480vector细胞相比,SW480Lgr5细胞中VEGF的蛋白含量明显增多,与SW620NC细胞相比,SW620Lgr5shRNA细胞VEGF的蛋白含量明显减少。通过Elisa发现,与SW480vector组相比,SW480Lgr5组中分泌VEGF的量明显增多(t=12.58,p0.01),与SW620NC组相比,SW620Lgr5shRNA组分泌VEGF的蛋白含量明显减少(t=8.104,p0.01)。 6. AOM/DSS模型中,肿瘤组织Lgr5与VEGF的mRNA表达明显增高 成功建立AOM/DSS模型,提取建模成功后的小鼠结肠组织RNA,行qRT-PCR显示,与对照组相比,实验组中Lgr5以及VEGF的mRNA的表达量明显升高(Lgr5:t=14.30, p0.01; VEGF:t=9.213, p0.01)。 7.敲低Lgr5的表达后,降低结直肠癌细胞在裸鼠体内的成瘤以及肝转移能力 在成瘤实验中,NC组的瘤体体积明显大于Lgr5shRNA组,并且这种显著差异在第3周开始体现出来。在裸鼠结肠癌肝转移实验中,与NC组相比,Lgr5shRNA组肝脏内癌结节数目明显较少(t=-4.386,p0.05)。 结论 通过以上实验结果,我们可以得出以下结论: 1.在体外,Lgr5可以促进结直肠癌细胞的迁移与侵袭能力; 2.在体内,Lgr5可以促进结直肠癌的成瘤以及肝转移; 3.Lgr5可以促进内皮细胞的血管生成,可以促进结直肠癌中VEGF的表达; 我们通过功能性获得与失去实验、体内外实验,发现在结直肠癌中,Lgr5可能是通过促进VEGF的表达,从而促进血管生成,最终促进肿瘤形成与转移。因而我们的研究可以为以Lgr5为靶点的治疗策略提供理论依据。
[Abstract]:Research background
Colorectal cancer has become one of the fastest growing malignant tumors in China. However, in colorectal cancer related deaths, most of them are caused by metastatic cancer. In recent years, more and more studies focus on tumor metastasis and explore the mechanism of tumor metastasis to reduce the occurrence of tumor metastasis and reduce the mortality of metastatic cancer. Guan Shengcheng is a very important link in the process of tumor growth and tumor metastasis. VEGF is an important factor promoting angiogenesis and also plays an important role in angiogenesis. At present, there are experiments to inhibit the formation of VEGF to inhibit tumor angiogenesis and inhibit tumor, but the inhibition of metastasis of colorectal cancer is unknown. Therefore, it is necessary to further study the mechanism of VEGF in the process of colorectal cancer formation and metastasis.
In recent years, Lgr5 has been found to be a specific marker of stem cell specific molecules in small intestine, colon, and hair follicle, and high expression of.Lgr5 is the target gene of Wnt signaling pathway in hepatocellular carcinoma, colon cancer, ovarian cancer, basal cell carcinoma and gastric cancer, and can regulate the activity of Wnt signaling pathway by feedback. More and more studies have shown that Lgr5 may also be a marker for cancer stem cells in colorectal cancer and can be used with other tumor stem cell markers for screening cancer stem cells in colorectal cancer. According to the "tumor stem cell theory", the data suggest that colorectal cancer may originate from the basement of the crypts of Lgr. 5 positive stem cells. This suggests that Lgr5 may play an important role in the development of colorectal cancer. However, there are few studies on the role and mechanism of Lgr5 in the process of tumor formation, development and metastasis. Our group has previously confirmed that the tumor's blood vessels could be suppressed after the low Lgr5 expression in colorectal cancer cells Generate.
research objective
In order to avoid the incidental results of Lgr5 expression, and to further explore the role of Lgr5 in colorectal cancer and its metastatic carcinoma, the effect of Lgr5 on VEGF and its mechanism will provide a theoretical basis for the treatment of colorectal cancer with Lgr5 as the target.
research method
1. construction of Lgr5 overexpression plasmid and establishment of stable cell line
The amplified primers were designed according to the sequence information of the complete human Lgr5 (NM_003667) gene sequence. The primer sequence was shown in Table 1. The primer amplification length was 2745bps. and was cloned into the pcDNA3.1 (+) eukaryotic expression vector. The sequence was correct. PcDNA3.1 (+) -Lgr5 plasmid and pcDNA3.1 (+) empty body particles were transfected into SW4 instantaneously by Lipofectamine2000. 80 cells were continuously screened by 1000ug/mlG418 for 48 hours, and then cloned and expanded for about 2-3 weeks to maintain 600ug/mlG418.
2. Western blotting
The total protein of the cell was extracted and the protein concentration was detected by the BCA protein quantitative kit. After the sample sample was 20 u g. electrophoresis, the protein was electrically transferred to the PVDF membrane, the 5% skimmed milk was closed, and a night resistance was incubated at 4. The first anti dilution ratio was (Lgr51:500, VEGF1:200, GAPDH1:1000, beta -actin).
1:1000), two days after incubation for 1 hours, ECL was developed by chemiluminescence.
3. real time fluorescence quantitative PCR (qRT-PCR)
The cells were extracted, the total RNA was organized and the concentration of RNA was measured. The first chain of cDNA was synthesized by the M-MLV reverse transcriptase. The real-time fluorescent quantitative PCR was carried out by the SYBR Premix Ex Taq kit of Takara. The primer sequence was shown in Table 1.
4. immuno histochemistry (SP method)
58 specimens of primary colorectal cancer in the southern hospital and 8 cases of metastatic carcinoma of colorectal cancer were collected, the tissues were fixed by 10% formalin, paraffin embedded, the specimens were cut into 4 micron m slices, 65 Centigrade oven roasted slices for 3 hours, and then dewaxing and hydrating, and using 0.01M sodium citrate buffer (pH6.0) to repair 15mmin with high temperature microwave, and the UltraSensitiveS-P hypersensitivity test of Maoxin company was used. The agent box, one anti 4 C refrigerator incubated for night (Lgr51:50, CD311:50), was coloured by DAB coloring agent, restained with hematoxylin, dehydrated transparent, sealed by wind, observed under microscope and filming. Two pathologist independently read the film and score.
5.HE staining
The tissue was fixed by 10% formalin, paraffin was embedded, the specimens were cut into 4 mu.M slices, and the roast slices of 65 Centigrade oven were about 30 minutes, and then dewaxing and hydrating in turn. The hematoxylin was stained for 2-5 minutes, 1% hydrochloric acid alcohol was differentiated, the water was washed to blue for 15 minutes, the eosin was stained for several seconds to several minutes, the dehydration was transparent, the seal was dried, under microscope observation and flapping.
6. Transwell compartment migration and invasion experiment
The concentration of 100u1 was added in the cell suspension with 1x106/ml in the upper chamber, then the medium of 500u1 containing 10%FBS was added to the lower chamber. After 24 hours culture, the cell was removed and 4% polyformaldehyde was fixed for 30 minutes, and the crystal violet was stained for 10 minutes. The residual cells in the upper chamber were wiped out with the cotton swab. The cells were randomly selected under the microscope microscope. The cells were counted and the cells were counted. The invasion experiment was carried out. In the upper chamber there is a layer of matrix adhesive, the rest of the methods and operations are in the same migration test.
7. tubule formation experiment
The medium was collected 48 hours after the plasmid transfection. The medium was filtered by the filter with the pore size of 0.22 Mn respectively. The medium was collected as the conditioned medium. The matrix gum was added to the 96 hole plate, each hole was added to 50ul, and the glue was cured for 1 hours at 37 C. The HMVEC cells with the concentration of 2 x 105/ml were added to each hole, and the corresponding conditioned medium was added. 0h, 2h, 4h, 8h were at 0h. The microtubule like structure of HMVEC cells was observed under the inverted microscope, and the number of closed tubular structures in the meso tube reticular structure was counted.
8. Elisa experiment
According to the operation instructions of human vascular endothelial growth factor (VEGF) Elisa Kit (Wuhan Huamei Biological Engineering Co., Ltd.), the concentration of VEGF in the recombinant cell culture medium was detected.
The establishment of 9. AOM/DSS model
5-6 weeks of balb/c mice were randomly divided into 2 groups, each group had 10 rats in each group. The experimental group was injected with AOM of the final concentration of 1.25mg/ml according to the dose of 12.5mg/kg (10ul/g), and the control group was injected with equal dose of saline in the abdominal cavity. The control group did not do special treatment. The experimental group was treated as the following: first weeks of normal drinking water; second weeks of drinking water containing 2.5%DSS, third, 4 weeks of continuous 2 weeks of normal drinking water, this is a cycle, this is a cycle of 5-10 weeks, repeat week 2,3,4 treatment 2 times, that is, a total of three cycles. Continue to feed to 17 weeks, kill the mice and take the colon tissue, observe the tumor body condition, the colon is fixed with 10% formalin, paraffin embedded, HE color. Extract the colon tissue RNA, and walk in real-time real-time quantitative PC fluorescence quantitative PC R detected the expression of Lgr5 and VEGF.
10. experimental tumor and liver metastases in nude mice
Tumor formation experiment in nude mice
5-6 weeks of Balb/c nude mice were randomly divided into 2 groups, 7 rats in each group, and the feeding grade was SPF grade. SW620Lgr5shRNA cells were injected respectively, SW620NC cells to the dorsal side of nude mice. The cell concentration was 1 x 107/ml, 200ul was injected, and the number of injected cells was 2 x 106. The tumor formation of nude mice was observed, the length of the nude mice was weighed every 3 days and the length of tumor (L) was measured and measured. A wide diameter (W) was used to calculate the volume of the tumor by formula L * w2/2. After.4 weeks, the nude mice were euthanized and the tumor was removed. The tumor was then embedded in 10% formalin fixed paraffin for subsequent HE staining.
Experimental liver metastases in nude mice with colorectal cancer
The early cell preparation was prepared with the nude mice, with 1% pentobarbital sodium 6-8ul/g injected into the nude mice by intraperitoneal injection of nude mice. The spleen was taken on the left back of the nude mice and the spleen was exposed. The spleen was injected along the upper margin of the spleen from the spleen to the tail of the spleen. The cells with 100ul concentration of 1 x 107/ml were injected into the splenic membrane slowly, and the abdominal cavity was cleaned after the injection was successful. The growth state of nude mice was observed and the nude mice were weighed every 3 days after.3 weeks. The nude mice were killed and the spleen, liver, lung and other tissues were removed, and 10% formalin fixed paraffin was embedded for subsequent HE staining.
Result
1. immunohistochemical results showed that the higher the expression of Lgr5 and the higher the microvessel density (MVD) were in colorectal cancer and metastatic cancer.
The expression of Lgr5 and vascular endothelial marker CD31 was detected by immunohistochemical staining in the specimens of primary colorectal cancer, lymph node metastasis and liver metastasis. It was found that the expression of Lgr5 was higher in lymph node metastasis and liver metastasis, and the expression of CD31 was also elevated, that is, the increase of microvascular density. The higher the expression of Lgr5 and the higher the microvessel density (MVD) in colorectal primary and metastatic cancers, however, the trend and the correlation between the two also need to be obtained by further increasing the sample size to obtain statistical data.
2. the successful construction of a stable cell line with high expression of Lgr5
The transfected Lgr5 recombinant overexpressed plasmid pcDNA3.1 (+) -Lgr5 and pcDNA3.1 (+) empty body particles entered SW480 and screened by G418. Western blotting and real-time fluorescent quantitative PCR technique were used to detect the protein and expression level of Lgr5 in SW480Lgr5 and SW480vector. The level of SW480Lgr5 increased significantly in Lgr5 cells, and the expression level of mRNA in SW480Lgr5 cells was also significantly increased (t=-17.499, P0.05).
Effects of 3.Lgr5 on migration and invasion of tumor cells
In the migration and invasion experiments, the number of migrating and invading cells in the SW480Lgr5 cell group increased significantly compared with the SW480vector cell group (migration: t=4.291, P0.05; invasion: t=3.127, P0.05); compared with the SW620NC cell group, the number of cells migrated and invaded by the SW620Lgr5shRNA cell group decreased significantly (migration: t=6.557, P0.01; invasion: t=2.297, P0.05).Transwell cell migration and invasion experiments showed that the migration and invasion ability of tumor cells increased obviously after the increase of Lgr5 expression, and the migration and invasion ability of tumor cells decreased significantly after knocking out Lgr5 expression.
Effect of 4.Lgr5 on endothelial cell tubule formation
The number of closed loop tubules formed by endothelial cells in Matrigel showed the ability to form endothelial cells. Compared with the SW480vector group, the tubule like structure in the SW480Lgr5 group increased significantly (t=8.617, P0.05). Compared with the SW620NC group, the number of tubules in the SW620Lgr5shRNA group decreased significantly (t=5.670, P0.05).
Effect of 5.Lgr5 on vascular endothelial growth factor in colorectal cancer cells
Compared with SW480vector cells, the protein content of VEGF increased significantly in SW480Lgr5 cells compared with SW480vector cells. Compared with SW620NC cells, the protein content of VEGF in SW620Lgr5shRNA cells decreased significantly. Compared with the SW480vector group, the amount of VEGF in SW480Lgr5 group increased significantly compared with the SW480vector group. Compared with group SW620Lgr5shRNA, the protein content of VEGF secreted significantly decreased (t=8.104, P0.01).
In the 6. AOM/DSS model, the expression of Lgr5 and VEGF mRNA in tumor tissues increased significantly.
The AOM/DSS model was successfully established to extract the RNA of mouse colon tissue after successful modeling, and qRT-PCR was shown. Compared with the control group, the expression of Lgr5 and VEGF in the experimental group increased significantly (Lgr5:t=14.30, P0.01; VEGF:t=9.213, P0.01).
7. knocking down the expression of Lgr5 decreases the tumorigenesis and liver metastasis of colorectal cancer cells in nude mice.
In the tumor formation experiment, the volume of the tumor body in the NC group was significantly larger than that in the Lgr5shRNA group, and the significant difference was found at third weeks. In the liver metastasis test of nude mice, the number of tumor nodules in the Lgr5shRNA group was significantly less than that in the NC group (t=-4.386, P0.05).
conclusion
From the above results, we can draw the following conclusions:
1. in vitro, Lgr5 can promote the migration and invasion of colorectal cancer cells.
2. in vivo, Lgr5 can promote tumor formation and liver metastasis of colorectal cancer.
3.Lgr5 can promote the angiogenesis of endothelial cells and promote the expression of VEGF in colorectal cancer.
Through functional acquisition and loss of experiments and in vitro and in vivo experiments, we found that in colorectal cancer, Lgr5 may promote angiogenesis by promoting the expression of VEGF, and ultimately promote tumor formation and metastasis. Therefore, our research can provide a theoretical basis for the therapeutic strategy targeting Lgr5.

【学位授予单位】:南方医科大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R735.34

【相似文献】

相关期刊论文 前10条

1 汪建平,王磊,杨祖立,黄奕华,董文广,覃建章,詹文华;青年结直肠癌的临床病理特征及预后[J];中华胃肠外科杂志;2002年04期

2 陈达民;老年多发性结直肠癌:手术与尸检病例的回顾性研究[J];国外医学(消化系疾病分册);2002年02期

3 静雨;;吸烟与结直肠癌[J];国外医学情报;2002年04期

4 黄萍,周紫垣,马恒太,刘晋yN,周燕虹,曹佳,葛海燕,余佩武,Toshiro Takezaki;重庆地区人群亚甲基四氢叶酸还原酶基因多态性与结直肠癌易感性关系研究[J];第三军医大学学报;2003年19期

5 李新宇,王杉,马向涛,叶颖江,崔志荣;细胞核因子κB抑制蛋白α的表达与结直肠癌临床病理特征的关系[J];中华普通外科杂志;2003年08期

6 曹文兰,布洁,白月奎,周良玉,张文政,武东风,卫亚希;Ⅳ期结直肠癌非手术治疗临床研究[J];肿瘤研究与临床;2003年06期

7 杨林,王金万;结直肠癌辅助治疗现状[J];癌症进展;2003年04期

8 耿稚江;;妇女应从50岁起接受结直肠癌的普查[J];国外医学情报;2003年07期

9 蒋沁婷,陈坤,邹艳,赵玉婉,马新源,李其龙,姚开颜,郑树;随访队列的结直肠癌危险因素的病例-对照研究[J];肿瘤;2004年01期

10 杨丹球,陈哲;结直肠癌患者外周血染色体脆性位点研究[J];中国优生与遗传杂志;2004年02期

相关会议论文 前10条

1 何超;朱洪波;;结直肠癌的生物治疗[A];2009年浙江省肿瘤外科学术年会暨肿瘤外科规范化诊治学习班论文汇编[C];2009年

2 万德森;;进一步提高结直肠癌疗效的思考[A];2009年浙江省肿瘤学术年会暨肿瘤诊治新进展学习班论文汇编[C];2009年

3 王哲海;;结直肠癌的诊断与系统性化疗[A];山东省第四届“CSCO——山东”首届肿瘤化疗学习班论文汇编[C];2009年

4 邓小梅;郑桂喜;王传新;张建;李伟;张晓;;结直肠癌患者血清蛋白质谱检测的意义[A];中华医学会第八次全国检验医学学术会议暨中华医学会检验分会成立30周年庆典大会资料汇编[C];2009年

5 李秉慧;李青科;韩梅;何立芳;陈书艾;;石家庄市及周边县区不同人群的结直肠癌危险因素的分析[A];第五届全国中医药免疫学术研讨会——暨环境·免疫与肿瘤防治综合交叉会议论文汇编[C];2009年

6 于丁;;结直肠癌的个体化治疗[A];湖北省胃肠肿瘤诊治进展研讨会论文汇编[C];2010年

7 丁义江;吴]岚;;结直肠癌的中医治疗[A];中医肛肠理论与实践——中华中医药学会肛肠分会成立三十周年纪念大会暨二零一零年中医肛肠学术交流大会论文汇编[C];2010年

8 杨怀中;杨宇飞;贾小强;吴寅莹;;结直肠癌防治未来展望[A];2010中国医师协会中西医结合医师大会摘要集[C];2010年

9 陈嘉;;结直肠癌个体化靶向治疗新理念[A];2010年江苏省抗癌协会第二届传统医学专业委员会学术研讨会资料汇编[C];2010年

10 巩跃生;魏淑娥;宋太平;张威;宋光瑞;;结直肠癌外科治疗新进展[A];中国肛肠病研究心得集[C];2011年

相关重要报纸文章 前10条

1 本报记者 贾岩;跨线治疗构筑结直肠癌最后防线[N];医药经济报;2012年

2 ;降低结直肠癌复发有新疗法[N];人民日报;2003年

3 韩自力;新化疗方案可高效治疗结直肠癌[N];健康报;2007年

4 齐攀;联合成像技术可以改善结直肠癌的诊断[N];医药经济报;2007年

5 常林;中国结直肠癌人数增长率达20%[N];医药经济报;2007年

6 宋奇思;青年型结直肠癌特点[N];家庭医生报;2008年

7 健康时报记者 刘桥斌;治结直肠癌前先查基因[N];健康时报;2009年

8 驻沪记者 魏峗;结直肠癌治疗十年取得重大进展[N];医药经济报;2009年

9 记者 李天舒;我国学者找到结直肠癌新靶标[N];健康报;2009年

10 记者 叶芳 通讯员 简文杨;专家呼吁把结直肠癌纳入常规体检[N];广东科技报;2009年

相关博士学位论文 前10条

1 刘常星;miR-143/miR-145在结直肠癌发病中的调节作用[D];复旦大学;2009年

2 赵光;结直肠癌血清比较蛋白质组学研究及特征多肽的功能研究[D];第二军医大学;2011年

3 陈坤;结直肠癌环境与宿主因素的流行病学研究[D];浙江大学;2003年

4 刘莉;脂联素及瘦素基因家族与结直肠癌[D];华中科技大学;2012年

5 陈伟光;结直肠癌相关微生态菌群及其宿主相互作用机制研究[D];浙江大学;2012年

6 周畅;MicroRNA-339-5p/3p在结直肠癌中作用的研究[D];南方医科大学;2013年

7 鞠海星;散发性结直肠癌的微卫星不稳定与染色体不稳定研究[D];浙江大学;2008年

8 徐芳英;结直肠癌预后评估及预测模型的建立[D];浙江大学;2009年

9 张艳玲;叶酸代谢酶相关基因多态性与结直肠癌易感性的关联研究[D];第三军医大学;2008年

10 张爽爽;有机氯化合物内暴露与结直肠癌发病风险的关联研究[D];浙江大学;2010年

相关硕士学位论文 前10条

1 柳俊刚;应用蛋白指纹图谱技术筛选结直肠癌及肝转移特异性相关蛋白的初步研究[D];广西医科大学;2010年

2 王德强;环境暴露下的错配修复基因多态性与结直肠癌易感性关系的研究[D];南京医科大学;2010年

3 郭立国;具有突变子表型散发性结直肠癌筛选策略研究[D];中国人民解放军军医进修学院;2005年

4 贺敬虎;白细胞介素-6在结直肠癌中的表达及临床意义[D];第二军医大学;2005年

5 范春红;药物代谢酶基因多态性、环境暴露与结直肠癌易感性关系的研究[D];浙江大学;2006年

6 马恒太;重庆地区人群营养膳食半定量食物频数问卷的制定与结直肠癌病例—对照标本库的建立[D];第三军医大学;2004年

7 刘林;miR-195/miR-365在结直肠癌发生发展中的调控作用及分子机制研究[D];中国人民解放军医学院;2012年

8 邓佳;二脂酰甘油酰基转移酶及脂肪酰胺水解酶在结直肠癌中的表达及临床意义[D];第三军医大学;2012年

9 阿尔夏提·阿衣提哈力;青年人结直肠癌临床病理特点分析[D];新疆医科大学;2013年

10 王巍巍;结直肠癌患者血清白细胞介素18的水平检测及其临床意义研究[D];山东大学;2008年



本文编号:1864531

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/mazuiyixuelunwen/1864531.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户50074***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com